This compound is a pharmaceutical intermediate used in the manufacturing of alpha1-adrenergic blockers. It serves as a key intermediate for the production of medications such as alfuzosin, prazosin, terazosin, doxazosin, and IAAP, which are effective as antihypertensives.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 28888-44-0
Lifitegrast Impurity 125
Pharmaceutical impurity reference standard
N-(5-((Diphenylphosphoryl)methyl)-4-(4-fluorophenyl)-6-isopropylpyrimidin-2-yl)-N-methylmethanesulfonamide
Pharmaceutical intermediate
Tert-Butyl 2-((4R,6S)-6-((E)-2-(4-(4-fluorophenyl)-6-isopropyl-2-(N-methylmethylsulfonamido)pyrimidin-5-yl)vinyl)-2,2-dimethyl-1,3-dioxan-4-yl)acetate
Rosuvastatin calcium intermediate
N-nitroso-tamsulosin
pharmaceutical reference standard
8-bromoquinazoline-2,4(1H,3H)-dione
research compound
6-Bromo-2,4(1H,3H)-quinazolinedione
Pharmaceutical intermediate compound
8-Chloro-6-fluoroquinazoline-2,4-diol
Pharmaceutical intermediate for quinazoline derivatives
7-Bromo-8-fluoro-6-(trifluoromethyl)quinazoline-2,4(1H,3H)-dione
Pharmaceutical intermediate
6,7-dimethoxy-1H-quinazoline-2,4-dione
KWNQIIMVPSMYEM-UHFFFAOYSA-N
COC1=C(C=C2C(=C1)C(=O)NC(=O)N2)OC